TORONTO, ONTARIO--(Marketwire - February 19, 2008) - OccuLogix, Inc. (NASDAQ: OCCX)(TSX: OC) announced today that it has secured a bridge loan in an aggregate principal amount of U.S.$3,000,000 from a number of private parties. The loan bears interest at a rate of 12% per annum and will have a 180-day term, which may be extended to 270 days under certain circumstances. The repayment of the loan is secured by a pledge by the Company of its 50.1% ownership interest in OcuSense, Inc. OcuSense, Inc. is a San Diego-based in vitro diagnostics company that is developing technologies to enable eye care practitioners to test for highly sensitive and specific biomarkers in tears at the point-of-care.
